Skip to content

The feasibility of multi-month delivery of antiretroviral therapy and its impact on clinical Outcomes and costs: A randomized, non-blind, non-inferiority study

The feasibility of multi-month delivery of antiretroviral therapy and its impact on clinical Outcomes and costs: A randomized, non-blind, non-inferiority study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066438
Enrollment
Unknown
Registered
2022-12-06
Start date
2022-12-06
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AIDS

Interventions

1 to 3 months of drug delivery group:delivery 1 to 3 months drugs
The 6-month drug delivery group:delivery 6 months drugs

Sponsors

The First Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Confirmed HIV-1 infection 2) Between the ages of 18 and 70; 3) Clinical stability of ART is defined as follows: - Take antiretroviral therapy for at least six months - No drug toxicity/tolerance problems in the first 6 months - There has not been a period of more than one month in the past six months when you have not received your medication - No active opportunistic infection (OI) was suspected at screening and no OI had been treated in the past 30 days - Undetected viral load in the past six months (< 200 copies /ml): - Not pregnant or nursing - Chronic complications (e.g., hypertension, diabetes, chronic lung disease, etc.) that do not occur in outpatient HIV treatment while receiving antiretroviral therapy 4) Willing and able to provide written informed consent 5) Plan to receive AIDS treatment in the same treatment facility for at least one year 6) Did not participate in any other studies affecting compliance, retention, or interval between receiving antiretroviral therapy

Exclusion criteria

Exclusion criteria: 1) Age under 18 or over 70 2) Those who do not want to sign the informed consent

Design outcomes

Primary

MeasureTime frame
HIV viral load;costs;

Secondary

MeasureTime frame
adverse effects;

Countries

Chian

Contacts

Public ContactHaibo Ding

The First Hospital of China Medical University

ding_haibo@126.com+86 13889875242

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 26, 2026